Skip to main content
Molimo sačekajte...

Kortokorezistentna Grejvsova orbitopatija – terapijske opcije

Reference
Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy. Front Endocrinol (Lausanne). 2020; 11: 1.
Men CJ, Kossler AL, Wester ST. Updates on the understanding and management of thyroid eye disease. Ther Adv Ophthalmol 2021; 13: 1–14. Kortokorezistentna Grejvsova orbitopatija – terapijske opcije 83
Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves’ dis
Sažetak

Kortokorezistentna Grejvsova orbitopatija – terapijske opcije

Medicinski glasnik

Vrednosti kalcitonina u pseudohipoparatiroidizmu

Ustanova
Klinika za endokrinologiju, dijabetes i bolesti metabolizma, Univerzitetski klinički centar Srbije
Klinički centar Srbije, Odelenje za bolesti štitaste žlezde
Sažetak

Vrednosti kalcitonina u pseudohipoparatiroidizmu

Medicinski glasnik